A4B-12640-34985
2 vaccinations
5 coded responses
10 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 221 / VA
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Registered in v-safe
-
2021-04-03
Dose 1 — Pfizer-BioNTech
-
2021-04-03
Survey response — day 0, dose 1MedDRA: Pruritus — Feeling: Fair · Headache, Fatigue or tiredness, NauseaFree text: Itchiness (full body)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Survey response — days 1–6 daily, dose 1MedDRA: Hypertension — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Very high blood pressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-10
- 2021-04-23
-
2021-04-24
Dose 2 — Pfizer-BioNTech
-
2021-04-24
Survey response — day 0, dose 2MedDRA: Dizziness — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Elevated blood pressure (significant even after medicated), nasal congestion, chest pains (intermittent), tachycardia (125- 160bpm), dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-24
Report sent to call center — day 0, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-10
Survey response — day 14, dose 2MedDRA: Chest pain — Feeling: FairFree text: Intermittent sharp chest pains located in anterior upper middle section of ribcage on both sides of chest. Usually one side or the other, worse when breathing during the pain. Occasionally occurs in pulses in tandem with pulse.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-23
Survey response — 6 months, dose 2MedDRA: Hypoaesthesia, Mobility decreased, Muscle spasms, Myalgia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Muscle spasms and pain with intermittent numbness and loss of function to lower extremitiesMedDRA releases: 2024-11 · check-in free text available
-
2021-10-23
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Pfizer-BioNTech | |
| 2 | 2021-04-24 | Pfizer-BioNTech |
Call center
2 call center cases
2 unsuccessful
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): Itchiness (full body)
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Very high blood pressure
Release 7 — day 0, dose 2
Systemic reaction (other): Elevated blood pressure (significant even after medicated), nasal congestion, chest pains (intermittent), tachycardia (125- 160bpm), dizziness
Release 8 — day 14, dose 2
Symptoms: Intermittent sharp chest pains located in anterior upper middle section of ribcage on both sides of chest. Usually one side or the other, worse when breathing during the pain. Occasionally occurs in pulses in tandem with pulse.
Release 10 — 6 months, dose 2
Symptoms: Muscle spasms and pain with intermittent numbness and loss of function to lower extremities
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Mobility decreased | · | · | ✓ |
| SD | Muscle spasms | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Hypertension | ✓ | ✓ | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release